HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The experimental and clinical antitumor action of the interferon inducer larifan].

Abstract
The paper presents the results of experimental and clinical studies on the antitumor effect of larifan. A statistically significant inhibition of growth of some continuous mouse tumors by larifan in a dose of 2.5 mg/kg given for 5-6 days and by a combination of larifan with an immunomodulator, inosiplex, tested on hepatoma XXIIa which has a rather low sensitivity to larifan. The antitumor effect of larifan may be due to interferon production and immunomodulating effect. Treatment with 0.05% larifan ointment of patients with cervical dysplasia of moderate degree resulted in a significant increase of previously diminished production of alpha-interferon after 10-14 vaginal tampons and clinical cure in 88% of cases. A course of 8-10-day larifan monotherapy given before radial therapy resulted in a considerable improvement in patients with cervical cancer of II-III stages, and subsequently, for 1 1/2-month combined radial therapy, no significant changes in production of alpha-IF were observed. At the same time, in patients with cervical cancer treated by radial therapy alone a significant decrease of alpha-IF production by blood mononuclears was observed by the end of therapy.
AuthorsM G Gasparian, N G Dzhagatspanian, R A Gevorkian, L A Kamalian
JournalVoprosy virusologii (Vopr Virusol) 1991 Mar-Apr Vol. 36 Issue 2 Pg. 127-30 ISSN: 0507-4088 [Print] Russia (Federation)
Vernacular TitleProtivoopukholevoe deÄ­stvie induktora interferona larifana v éksperimente i klinike.
PMID1909072 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Interferon Inducers
  • Organic Chemicals
  • larifan
  • Interferon-gamma
Topics
  • Administration, Intravaginal
  • Animals
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Combined Modality Therapy
  • Drug Evaluation
  • Drug Screening Assays, Antitumor
  • Female
  • Interferon Inducers (administration & dosage, therapeutic use)
  • Interferon-gamma (blood)
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Neoplasms, Experimental (drug therapy, immunology)
  • Organic Chemicals
  • Uterine Cervical Dysplasia (drug therapy, immunology)
  • Uterine Cervical Neoplasms (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: